{
    "clinical_study": {
        "@rank": "121019", 
        "acronym": "SUFEMYO", 
        "arm_group": [
            {
                "arm_group_label": "thalassemia", 
                "description": "patients affected with thalassemia"
            }, 
            {
                "arm_group_label": "sickle cell disease", 
                "description": "patients affected with sickle cell disease"
            }, 
            {
                "arm_group_label": "myelodysplasia", 
                "description": "patients affected with myelodysplasia"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators' primary objective is to study prevalences of myocardial iron overload,\n      defined as a cardiac T2*< 20 ms, in 3 populations of multiply transfused patients, affected\n      with thalassemia, sickle cell disease, and myelodysplasia."
        }, 
        "brief_title": "Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Thalassemia", 
            "Sickle Cell Disease", 
            "Myelodysplasia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anemia, Sickle Cell", 
                "Myelodysplastic Syndromes", 
                "Preleukemia", 
                "Thalassemia", 
                "Iron Overload"
            ]
        }, 
        "detailed_description": {
            "textblock": "The inevestigators' primary objective is to study prevalences of myocardial iron overload,\n      defined as a cardiac T2*< 20 ms, in 3 populations of multiply transfused patients, affected\n      with thalassemia, sickle cell disease, and myelodysplasia.\n\n      The investigators will record concomitantly parameters which, according to literature data,\n      may influence the occurrence of this complication, and will look for correlations with these\n      parameters and iron overload (secondary objectives), in each of the 3 cohorts.\n\n      14 centres are involved and enrol patients with thalassemia, or sickle cell disease, or\n      myelodysplasia having received in the past year > 8 erythrocyte concentrates, and having had\n      a cardiac MRI. Patients files register the type of the disease, age at the beginning of\n      transfusion and chelation, chelator type and dosage, liver and cardiac T2*."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Thalassemia, sickle cell disease, myelodysplasia\n\n          -  having received in the past year > 8 erythrocyte concentrates\n\n          -  > 6 years of age\n\n        Exclusion Criteria:\n\n          -  preexisting cardiac disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "6 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients affected with thalassemia, SCD, and myelodysplasia"
            }
        }, 
        "enrollment": {
            "#text": "210", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01911871", 
            "org_study_id": "NI10071", 
            "secondary_id": "RAF11005"
        }, 
        "intervention": {
            "arm_group_label": [
                "thalassemia", 
                "sickle cell disease", 
                "myelodysplasia"
            ], 
            "description": "a blood sample was taken on the day of inclusion", 
            "intervention_name": "Blood sample", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Thalassemia", 
            "sickle cell disease", 
            "myelodysplasia", 
            "transfusion", 
            "chelation"
        ], 
        "lastchanged_date": "July 29, 2013", 
        "location": {
            "contact": {
                "email": "mariane.demontal@nck.aphp.fr", 
                "last_name": "Mariane de Montalembert, MD/PHD", 
                "phone": "00 33 1 44 49 48 96"
            }, 
            "contact_backup": {
                "email": "laurence.lecomte@cch.aphp.fr", 
                "last_name": "Laurence Lecomte, PhD", 
                "phone": "00 33 1 58 41 35 45"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75015"
                }, 
                "name": "H\u00f4pital Necker Enfants Malades"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "3", 
        "official_title": "Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations", 
        "overall_contact": {
            "email": "mariane.demontal@nck.aphp.fr", 
            "last_name": "Mariane de Montalembert, MD/PHD", 
            "phone": "00 33 1 44 49 48 96"
        }, 
        "overall_contact_backup": {
            "email": "laurence.lecomte@nck.aphp.fr", 
            "last_name": "Laurence Lecomte, PhD", 
            "phone": "00 33 1 58 41 35 45"
        }, 
        "overall_official": {
            "affiliation": "Groupement Hospitalier Necker", 
            "last_name": "Mariane de montalembert, MD/PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Cardiac T2* (MRI)", 
            "safety_issue": "No", 
            "time_frame": "Day 0"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01911871"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Liver T2*(MRI)", 
            "safety_issue": "No", 
            "time_frame": "Day 0"
        }, 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "collaborator": {
                "agency": "Novartis", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}